相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Challenging the axiom: does the occurrence of oncogenic mutations truly limit cancer development with age?
J. DeGregori
ONCOGENE (2013)
Distinct roles for long-term hematopoietic stem cells and erythroid precursor cells in a murine model of Jak2V617F-mediated polycythemia vera
Ann Mullally et al.
BLOOD (2012)
FLT3-ITD Knockin Impairs Hematopoietic Stem Cell Quiescence/Homeostasis, Leading to Myeloproliferative Neoplasm
S. Haihua Chu et al.
CELL STEM CELL (2012)
Effects of the JAK2 mutation on the hematopoietic stem and progenitor compartment in human myeloproliferative neoplasms
Shubha Anand et al.
BLOOD (2011)
New mutations and pathogenesis of myeloproliferative neoplasms
William Vainchenker et al.
BLOOD (2011)
Strategies for Homeostatic Stem Cell Self-Renewal in Adult Tissues
Benjamin D. Simons et al.
CELL (2011)
Mouse models of myeloproliferative neoplasms: JAK of all grades
Juan Li et al.
DISEASE MODELS & MECHANISMS (2011)
Clonal analysis reveals multiple functional defects of aged murine hematopoietic stem cells
Brad Dykstra et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms
Franz X. Schaub et al.
BLOOD (2010)
Myeloproliferative neoplasm induced by constitutive expression of JAK2V617F in knock-in mice
Caroline Marty et al.
BLOOD (2010)
BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells
Mirle Schemionek et al.
BLOOD (2010)
Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease
Hajime Akada et al.
BLOOD (2010)
JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia
Juan Li et al.
BLOOD (2010)
Distinct Clinical Phenotypes Associated with JAK2V617F Reflect Differential STAT1 Signaling
Edwin Chen et al.
CANCER CELL (2010)
Physiological Jak2V617F Expression Causes a Lethal Myeloproliferative Neoplasm with Differential Effects on Hematopoietic Stem and Progenitor Cells
Ann Mullally et al.
CANCER CELL (2010)
Intestinal Crypt Homeostasis Results from Neutral Competition between Symmetrically Dividing Lgr5 Stem Cells
Hugo J. Snippert et al.
CELL (2010)
Clonal chromosomal abnormalities in CD34+/CD38- hematopoietic cells from cytogenetically normal chronic myeloid leukemia patients with a complete cytogenetic response to tyrosine kinase inhibitors
T. Bumm et al.
LEUKEMIA (2010)
Insights into the stem cells of chronic myeloid leukemia
I. Sloma et al.
LEUKEMIA (2010)
Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F
Franz X. Schaub et al.
BLOOD (2009)
Prospective isolation and molecular characterization of hematopoietic stem cells with durable self-renewal potential
David G. Kent et al.
BLOOD (2009)
ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays
Yifang Hu et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
Mutation in TET2 in Myeloid Cancers
Francois Delhommeau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity
Chloe James et al.
BLOOD (2008)
The JAK2V617F mutation can occur in a hematopoietic stem cell that exhibits no proliferative advantage:: a case of human allogeneic transplantation
Kristien Van Pelt et al.
BLOOD (2008)
Steel factor coordinately regulates the molecular signature and biologic function of hematopoietic stem cells
David G. Kent et al.
BLOOD (2008)
A new mechanism for the aging of hematopoietic stem cells: aging changes the clonal composition of the stem cell compartment but not individual stem cells
Rebecca H. Cho et al.
BLOOD (2008)
JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders
Isabelle Plo et al.
BLOOD (2008)
Phenotypic variability within the JAK2 V617F-positive MPD: Roles of progenitor cell and neutrophil allele burdens
Alison R. Moliterno et al.
EXPERIMENTAL HEMATOLOGY (2008)
The allele burden of JAK2 mutations remains stable over several years in patients with myeloproliferative disorders
Alexandre Theocharides et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Inhibition of the Bcl-xL Deamidation Pathway in Myeloproliferative Disorders
Rui Zhao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Detection of the JAK2V617F mutation in patients with slightly elevated platelets or hemoglobin without a secondary cause
Leonie Strobbe et al.
ANNALS OF HEMATOLOGY (2007)
Behavior of CD34+ cells isolated from patients with polycythemia vera in NOD/SCID mice
Takefumi Ishii et al.
EXPERIMENTAL HEMATOLOGY (2007)
The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera
Sabrina Dupont et al.
BLOOD (2007)
Long-term propagation of distinct hematopoietic differentiation programs in vivo
Brad Dykstra et al.
CELL STEM CELL (2007)
Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment
Carl R. Walkley et al.
CELL (2007)
Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age
Derrick J. Rossi et al.
NATURE (2007)
Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells
Xiaoyan Jiang et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
A single type of progenitor cell maintains normal epidermis
Elizabeth Clayton et al.
NATURE (2007)
JAK2(V617F): prevalence in a large Chinese hospital population
Xuesong Xu et al.
BLOOD (2007)
Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders
Ross L. Levine et al.
NATURE REVIEWS CANCER (2007)
Mutation of JAK2 in the myeloproliferative disorders:: timing, clonality studies, cytogenetic associations, and role in leukemic transformation
Peter J. Campbell et al.
BLOOD (2006)
Hematopoietic stem cells - The paradigmatic tissue-specific stem cell
David Bryder et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention
Jiwang Zhang et al.
NATURE (2006)
High-resolution video monitoring of hematopoietic stem cells cultured in single-cell arrays identifies new features of self-renewal
Brad Dykstra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation
CHM Jamieson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The hematopoietic stem compartment consists of a limited number of discrete stem cell subsets
HB Sieburg et al.
BLOOD (2006)
Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status:: a prospective study
PJ Campbell et al.
LANCET (2005)
JAK2V617F mutation in essential thrombocythaemia:: clinical associations and long-term prognostic relevance
AP Wolanskyj et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Clinical implications of the JAK2 V617F mutation in essential thrombocythemia
E Antonioli et al.
LEUKEMIA (2005)
Murine hematopoietic stem cells change their surface phenotype during ex vivo expansion
CC Zhang et al.
BLOOD (2005)
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
C James et al.
NATURE (2005)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
RL Levine et al.
CANCER CELL (2005)
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
CHM Jamieson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Hematopoietic stem cell quiescence maintained by p21cip1/waf1
T Cheng et al.
SCIENCE (2000)
分享论文
